04 Apr 2023 Wellbeing

£200 grants for people affected by leukaemia once again available

Leukaemia UK and Leukaemia Care have this month relaunched the ‘Cost of Living Fund’, providing financial grants of £200 to patients with leukaemia, myelodysplastic syndrome (MDS) or myeloproliferative neoplasms (MPNs), whose lives have been impacted by the ongoing cost of living crisis. 

Applications are open now for grants of up to £200 provided by the Leukaemia UK and Leukaemia Care ‘Cost of Living Fund’. Over £168,000 was given to families affected by leukaemia, MDS or an MPN in 2022. Together, Leukaemia UK and Leukaemia Care hope that the relaunch of this fund will provide much-needed support during one of the most difficult times of a person’s life. 

Fiona Hazell, Chief Executive of Leukaemia UK, said: 

“The relaunch of the Cost of Living with Leukaemia Fund will help to improve the lives of more people across the UK living with leukaemia. The emotional and physical challenges of leukaemia are profound, and the diagnosis often brings additional financial pressures during what is already one of the most difficult times of a person’s life. The Cost of Living with Leukaemia Fund will make a tangible difference to their lives, and we are very grateful to our supporters for making this relaunch possible.” 

Please visit the Leukaemia Care website to find out more. 

Related posts

Local eateries can help to cook up change with new charity initiative

15 May 2024

Local eateries can help to cook up change with new charity initiative

Pubs, bars and restaurants across the country are being called upon to get involved with Leukaemia UK’s Cooking Up Change to raise money for vital research into leukaemia and related…

£200 grants for people affected by leukaemia once again available

4 April 2023

£200 grants for people affected by leukaemia once again available

Leukaemia UK and Leukaemia Care have this month relaunched the ‘Cost of Living Fund’, providing financial grants of £200 to patients with leukaemia, myelodysplastic syndrome (MDS) or myeloproliferative neoplasms (MPNs),…

Together we are changing lives – Here’s how your support is making it happen

3 July 2025

Together we are changing lives – Here’s how your support is making it happen

At this point in our advocacy journey, we wanted to share an update to you, our supporters, on everything we’ve achieved so far and what’s next as we continue to…

Improving access to life-changing treatment – Leukaemia UK’s role in the approval of Aucatzyl

25 November 2025

Improving access to life-changing treatment – Leukaemia UK’s role in the approval of Aucatzyl

Today, NICE announced its recommendation for Aucatzyl (obecabtagene autoleucel), a CAR-T therapy, to be made available on the NHS for treating adults aged 26 and over with relapsed or refractory…